Schrodinger

SDGRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.164 B

$28.82 +1.05%

Close of 6 Nov 2026

As of 6 Nov 2026, Schrodinger (SDGR) has a market capitalization of $2.16B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$255.9M

#2183 by revenue

Earnings

-$103.3M

Loss-making

Shares outstanding

74,525,590

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#90Vera TherapeuticsVERA$2.17B
#91Aurinia PharmaceuticalsAUPH$2.17B
#92SchrodingerSDGR$2.16B
#93ImmunomeIMNM$2.13B
#94Prestige Consumer HealthcarePBH$2.11B

What if Schrodinger were worth as much as…

Open the what-if tool →

Gold $28.2T

$376,101.54

Per share 13,050× higher

Bitcoin $1.53T

$20,350.20

Per share 706× higher

Apple $5.02T

$66,807.80

Per share 2,318× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Schrodinger are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.